Recent studies have suggested that chito-oligosaccharides can have anti-adipogenic properties. The objectives of the present study were to evaluate the anti-adipogenic potential of four different chito-oligosaccharides (molecular weight (MW) ,1000, 1000 -3000, 3000-5000 and 5000-10 000 Da) and to identify molecular mechanisms underlying the chito-oligosaccharide-mediated inhibition of adipogenesis. Mouse 3T3-L1 cells were allowed to differentiate in the presence of chito-oligosaccharide. At day 8 post-induction of differentiation, lipid accumulation, free glycerol release and the quantitative expression of adipogenic marker genes were evaluated. Chito-oligosaccharides had concentration-and MW-dependent inhibitory effects on lipid accumulation (P,0·001 and , 0·05, respectively), as well as a concentration-dependent effect (P,0·001) on free glycerol release and the expression of adipogenic marker genes. The 5000 -10 000 Da chito-oligosaccharide was selected for subsequent molecular studies. A panel of forty-four lipid metabolic pathwayspecific genes was analysed by quantitative real-time PCR. Chito-oligosaccharide-mediated inhibition of adipogenesis was associated with the up-regulation of the IL-6 gene at all concentrations of chito-oligosaccharide examined and the PG-endoperoxide synthase 2 (PTGS2) gene at higher concentrations of chito-oligosaccharide. The effect of chito-oligosaccharide on gene expression was validated by measuring IL-6 protein concentrations in the media. Finally, an IL-6 promoter assay was developed to characterise the effect of chito-oligosaccharide on the transcriptional activity of the IL-6 promoter, which was increased in a concentration-dependent manner (P,0·001). We conclude that IL-6 is a candidate signalling molecule in the chito-oligosaccharide-mediated inhibition of adipogenesis in 3T3-L1 cells.
Obesity is characterised by the accumulation of excessive body fat, which is associated with a range of major diseases including type 2 diabetes, hypertension, CVD and arthritis (1) . Inhibition of adipogenesis through the ingestion of functional foods such as chitosan can reduce the deposition of excessive fat in adipose tissue (2, 3) . Chitosan is a polymer of b-(1 ! 4)-2acetamido-D-glucose and b-(1 ! 4)-2-amino-D-glucose (2, 4) . It is synthesised through the chemical modification of chitin, which forms the hard shells of crustaceans such as crabs and shrimps (4, 5) . Chitosan is a non-toxic nutritional supplement generally regarded as a safe compound (6 -8) . Chitosan has been investigated for its therapeutic potential as an antiobesity, anti-microbial and antioxidant agent (3, 9) . Recent studies have indicated that chitosan can inhibit absorption of lipids in human subjects and animals, which is based on the fact that chitosan can readily bind dietary lipids in the proximal region of the small intestine of the mammalian gastrointestinal tract (3,10 -12) .
Native chitosan polymers generally have a very high molecular weight (MW). It is associated with low solubility and high viscosity, which limits its cellular absorption (12, 13) . Hence, to enhance biological activity, chitosan is often modified to form chito-oligosaccharide, which has a lower MW, lower viscosity and higher solubility (14, 15) . Chito-oligosaccharide can be absorbed by mammalian cells and can participate in metabolic processes within a cell (8, 12, 16) . However, the degree of absorption and intracellular activity of chitooligosaccharide is highly dependent on the MW, solubility and deacetylation percentage (7, 8, 12) , with low-MW chitooligosaccharide readily absorbed by intestinal cells in vitro and in vivo (8, 12) .
The murine 3T3-L1 pre-adipocyte cell line has previously been used as an in vitro model system for investigating the molecular mechanisms of adipogenesis (17 -19) . These fibroblast cells can be stimulated to differentiate into mature adipocytes, a process which mimics the maturation of adipose precursor cells and deposition of lipids during the development of obesity in humans (20) . In addition to playing a vital endocrine role in energy homeostasis, adipocytes are the primary sites of energy storage, where the excess energy is stored in the form of TAG (21) . Recent studies have demonstrated that chitooligosaccharides have the potential to alter the expression level of a number of genes involved in adipogenesis, including PPARg, CCAAT/enhancer-binding protein (CEBPa), leptin, adiponectin (ADIPOQ) and resistin in adipocytes and mouse models (3, 22) .
Adipogenesis occurs through the activation of biochemical pathways mediated through signalling molecules including cytokines, chemokines and adipokines (23, 24) . One of the fundamental biochemical pathways vital to adipogenesis is the lipid metabolic pathway. The mode of action of chito-oligosaccharide as an anti-adipogenic compound has not yet been characterised. We hypothesised that anti-adipogenic chito-oligosaccharides will alter the expression of genes involved in the lipid metabolic pathway. Hence, the objectives of the present study were, first, to evaluate four chito-oligosaccharides for their concentration-and MW-dependent effects on the adipogenesis of mouse 3T3-L1 pre-adipocyte cells. Having identified the chito-oligosaccharide with the greatest anti-adipogenic potential, we subsequently evaluated its effect on the expression of a panel of genes involved in lipid metabolism and further validated the expression and regulation of the differentially expressed candidate gene at protein and gene promoter levels.
Materials and methods

Cell culture
Mouse 3T3-L1 pre-adipocytes were obtained from the American Type Culture Collection (Manassas, VA, USA). Cells were cultured in a Dulbecco's modified Eagle's medium (DMEM; Gibco, Invitrogen Corporation, San Diego, CA, USA) containing 10 % fetal calf serum (Gibco) and 1 % penistrep solution (Sigma-Aldrich Corporation, St Louis, MO, USA) in a 378C humidified incubator with 5 % CO 2 . During the multiplication phase of the pre-adipocytes, the medium was changed every alternate day and the cells were trypsinised before reaching full confluence and were plated afresh.
Chito-oligosaccharides
A total of four chito-oligosaccharides of MW , 1000, 1000-3000 (1-3000), 3000-5000 (3 -5000) and 5000-10 000 (5 -10 000) Da were sourced from Kitto Life Company Limited (Kyungki-do, Seoul, Korea). Both the chito-oligosaccharide content and the deacetylation percentage of all of these chito-oligosaccharides were .70 %. For the cell culture experiment, chito-oligosaccharide stock solution (100 mg/ml) was made using DMEM basal medium and introduced at final concentrations of 600, 1200, 2400 and 4800 mg/ml. DMEM basal medium was used as a carrier control. This range of concentration was based on a previous study where a concentration of 4000 mg/ml chito-oligosaccharide was used in the mouse 3T3-L1 cells and no adverse cytotoxic effect has been reported (3) .
Cell viability and cytotoxicity test
Initially, cell viability and cytotoxicity of the mouse 3T3-L1 cells were assessed in response to a range of concentrations of the different MW chito-oligosaccharides. 3T3-L1 cells were plated in a ninety-six-well cell culture plate (Greiner Bio-One Gmbh, Frickenhausen, Germany) at an initial plating density of 6 £ 10 4 cells/ml. First, the cells were allowed to reach full confluence and then kept at a fully confluent state for 24 h before treating with chito-oligosaccharide. On the day of treatment, cells were washed with sterile PBS (Sigma-Aldrich) and incubated with serum-and antibiotic-free medium, containing chito-oligosaccharide at final concentrations of 0, 600, 1200, 2400 and 4800 mg/ml, for 24 and 48 h. Cell viability test was performed on the cell monolayer, using the 3-(4,5-dimethyl-2-yl)-2,5-diphenyltetrazolium bromide (Sigma-Aldrich) test. Cell cytotoxicity was evaluated with 25 ml cell lysate, using the Tox-7 kit (Sigma-Aldrich).
Assessment of the anti-adipogenic potential of chito-oligosaccharides
Cells were cultured to full confluence and adipogenesis was induced in the presence of a range of concentrations of chito-oligosaccharide. Intracellular lipid accumulation was visualised, free glycerol was measured and the quantitative expression of four adipogenic marker genes was determined and compared with untreated cells, as described below.
Adipogenesis
Mouse 3T3-L1 cells (6 £ 10 4 cells/ml) were cultured in DMEM containing 10 % fetal calf serum and 1 % penistrep solution in a twelve-well cell culture plate (Greiner Bio-One Gmbh) in a 378C humidified incubator with 5 % CO 2 . Before induction of adipogenesis, the pre-adipocytes were allowed to reach full confluence and grown for 48 h. Adipogenesis was induced (day 0) by introducing the DMEM containing 10 % fetal bovine serum (Gibco), 0·5 mM-3-isobutyl-1-methylxanthine (Sigma-Aldrich), 0·25 mM-dexamethasone (Sigma-Aldrich) and bovine insulin (10 mg/ml; Sigma-Aldrich) and 1 % penistrep (differentiation induction medium). After 48 h of incubation with the induction medium (day 2), the medium was removed and post-differentiation medium (DMEM, 10 % fetal bovine serum, bovine insulin (5 mg/ml) and 1 % penistrep) was introduced and incubated for 48 h. Then (day 4), the postdifferentiation medium was removed and the cells were grown in DMEM containing 10 % fetal bovine serum and 1 % penistrep, and the medium was changed after every 48 h until the cells were harvested at day 8 of induction of adipogenesis. During the process of adipogenesis, chito-oligosaccharides were added to the medium in every alternate day from day 0 to 8 at final concentrations of 0, 600, 1200, 2400 and 4800 mg/ml.
Determination of lipid accumulation
At day 8 of induction of adipogenesis, the medium was removed and the cells were washed using sterile PBS (Sigma-Aldrich) and then fixed by using 10 % formalin solution (Sigma-Aldrich). Oil Red O staining of the adipocytes was performed as described previously (25) . Counter staining was performed using 1 ml of haematoxylin (Sigma-Aldrich) solution per well. The adipocytes were evaluated under a microscope and the image captured were analysed using Image-Pro 5.0 software (Media Cybernetics, Inc., Bethesda, MD, USA). Six random microscopic fields per treatment were captured at a microscopic resolution of 10 £ and the Oil Red O stain was quantified and is expressed as the ratio of the area stained with Oil Red O and the total area of the microscopic field.
Determination of free glycerol
Glycerol release by the adipocyte is an indirect reflection of the TAG status of the cell (26, 27) . Free glycerol estimation was performed on the medium harvested at day 8 of the induction of adipogenesis. Free glycerol was estimated on 5 ml of the cell lysate using the Enzychrom glycerol assay kit (BioAssay Systems, Hayward, CA, USA), following the manufacturer's instructions.
RNA extraction
To compare the expression of four adipogenic marker genes in the cells following exposure to the different MW chito-oligosaccharides, RNA was extracted from the cells, complementary DNA (cDNA) was synthesised and used for quantitative realtime PCR analyses. At day 8 of induction of adipogenesis, the medium was removed and the cell monolayer was washed with sterile PBS and the cells were collected in 1 ml TRI reagent (Applied Biosystems, Foster City, CA, USA). Total RNA was extracted using the Trizol method according to the manufacturer's instructions. RNA was dissolved in 20 ml of nuclease-free water and then subjected to deoxyribonuclease I (Sigma-Aldrich) treatment to eliminate the genomic DNA contamination. Column purification of RNA was performed using the GenElute mammalian total RNA miniprep kit (Sigma-Aldrich). RNA was finally eluted in 40 ml of nuclease-free water. The quality and quantity of total RNA were assayed by analysing 1 ml of total RNA on an Agilent 2100 Bioanalyser (Agilent Technologies, Inc., Santa Clara, CA, USA) using RNA Nano LabChips w (Caliper Technologies Corporation, Hopkinton, MA, USA). All RNA samples used for the gene expression study had an RNA integrity value $8·0.
Quantitative real-time PCR
cDNA synthesis was performed with 1 mg of total RNA, using the RevertAid H minus first-strand cDNA synthesis kit (Fermentas GmbH, St Leon-Rot, Germany) following the manufacturer's protocol. The quantitative expressions of four adipogenic marker genes (glyceraldehyde 3-phosphate dehydrogenase (GAPDH), PPARg, CEBPa and ADIPOQ) and b-actin (ACTB) as a reference gene were evaluated using a 7300 Real-Time PCR System (Applied Biosystems). The PCR mixture (20 ml) contained 1 ml cDNA (after 1:5 dilution), 1 ml forward and reverse primer mix, 8 m1 water and 10 ml SYBR green master mix (Applied Biosystems). The thermal cycle conditions were 948C for 30 s, followed by 608C for 1 min, for forty cycles. The mRNA abundances are expressed in C t values, the number of PCR cycles after which the PCR product crosses a threshold value. Each sample was run in triplicate and C t values , 35 were used for analysis.
Identification of molecular mechanisms of action of chito-oligosaccharides
Based on the results obtained on the anti-adipogenic potential of the chito-oligosaccharides, 3T3-L1 cells were treated with one chito-oligosaccharide (MW 5 -10 000 Da) at a range of final concentrations of 0, 600, 2400 and 4800 mg/ml. The gene expression profile of forty-four genes involved in the mouse lipid metabolic pathway was assessed in these cells. As the IL-6 gene was identified as the most sensitive gene of the forty-four genes analysed, the IL-6 gene expression data were validated at the protein level, using an ELISA assay. An IL-6 promoter assay was also developed to determine whether the promoter activity would reflect the gene expression data. The details of these methods are outlined below.
Lipid metabolic pathway genes
The quantitative expression of a panel of genes involved in lipid metabolism in mice was evaluated using 'TaqMan Array for Mouse Lipid Regulated Genes 96-Well Plate' (Applied Biosystems) in a 7300 Real-Time PCR System (Applied Biosystems). This is a pre-customised array, which enables screening of forty-four different genes involved in mouse lipid metabolism. According to the manufacturer, the genes included in this array had either established or a potential role in lipid metabolism, and hence it was considered suitable to screen chito-oligosaccharide-mediated inhibition of adipogenesis. Real-time RT-PCR was performed in a 20 ml reaction mixture/well containing 1 ml cDNA (after 1:5 dilution), 9 ml water and 10 ml TaqMan gene expression master mix (Applied Biosystems). The thermal cycle conditions used were as stated above.
Normalisation of the expression of the target genes included in the PCR array was performed based on two reference genes (hypoxanthine guanine phosphoribosyl transferase 1 (HPRT1) and b-glucuronidase (GUSB) and following the 2 -DDC t method (28) . Briefly, average DC t was calculated as the difference of C t values of any target gene minus average of the C t value of the two reference genes. Then, fold change was calculated as 2 (2 average DCt target gene) /2 (2 average DCt reference gene) .
Promoter activation assay
Promoter construct. A 1065 bp fragment of the regulatory region (stretching from 2 1064 to þ1 bp relative to the transcription start site) of the human IL-6 gene was amplified by PCR. The forward primer (5 0 -CCTTAGATCTCTGCGTCCGT-AGTTTCCTTC-3 0 ) was designed to include a Bgl II restriction site (italicised). The reverse primer (5 0 -GAGTAAGCTTTGAGC-CTCAGACATCTCCAG-3 0 ) incorporated a Hind III restriction enzyme site (italicised) plus a four-nucleotide anchor at the 5 0 end. PCR amplification was performed in a PTC-225 DNA Engine Tetrad (MJ Research, Inc., Waltham, MA, USA) using 1X Platinum PCR SuperMix High fidelity (Invitrogen Corporation), 0·2 mM of each of the forward and reverse primers and 50 ng of human genomic DNA (Promega Corporation, Madison, WI, USA) in a total volume of 100 ml. The PCR cycle conditions were as follows: initial 948C for 2 min followed by thirty-nine cycles of 948C for 45 s, 608C for 45 s and 708C for 1 min followed by a final extension of 728C for 10 min. The PCR product (1065 bp) was assessed on a 1·3 % agarose gel stained with ethidium bromide. Cloning of the PCR product into firefly luciferase expression vector pGL4.17 (Promega Corporation) was performed, as described previously (29) . Transfection-grade endotoxin-free plasmid construct containing the human IL-6 promoter insert was prepared using the EndoFree Plasmid Maxi kit (Qiagen, Chatsworth, CA, USA).
Cell culture and transient transfection assay
The day before the transfection assay, 3T3-L1 cells (6 £ 10 4 cells/ml) were initially cultured in DMEM containing 10 % fetal calf serum in a twenty-four-well cell culture plate (Greiner Bio-One GmbH) in a 378C humidified incubator with 5 % CO 2 . The transfection cocktail (for each well) contained 25 ml DMEM basal medium, 0·3 ml FuGENE HD transfection reagent (Roche Diagnostics GmbH, Mannheim, Germany) and 100 ng of IL-6 promoter construct DNA. Following incubation at room temperature for 15 min, this cocktail was introduced dropwise onto the cells. The cells were grown on a DMEM containing 10 % fetal calf serum until the fully confluent state was attained. After 48 h of attaining full confluence, the cells were treated with chito-oligosaccharide in (1) a serum-free basal medium or (2) a serum-containing differentiation induction medium, as described earlier.
Transiently transfected cells were allowed to grow for 24 h and luciferase assay was performed using the Luciferase Reporter Assay system (Promega Corporation). In brief, the medium was removed and the cells were washed with 500 ml PBS. Lysis of the cells was performed by adding 250 ml of passive lysis buffer (Promega Corporation), followed by incubation at 378C in a shaking incubator for 30 min at 700 rpm. Firefly-relative luciferase unit activity was measured in 20 ml of the cell lysate in a 20/20n Single Tube Luminometer (Turner Biosystems, Inc., Sunnyvale, CA, USA).
IL-6 ELISA
To support the gene expression data, a time-course study was set up to measure the IL-6 protein levels in the medium over the course of the experiment. The cell culture medium was harvested at days 2, 4 and 8 of the induction of adipogenesis and stored at 2 808C until used for analysis. Abundance of IL-6 in the culture medium was measured using the mouse IL-6 duo set ELISA development system (R&D Systems Europe, Limited, Abingdon, UK), following the manufacturer's instructions. Absorbance was measured at 450 nm against 570 nm using the ELISA plate reader. The assay was performed in duplicate for each sample.
Statistical analysis
For the Oil Red O data, each data point of the three independent assays represents the mean of six random microscopic fields per treatment. The Oil Red O and free glycerol data are expressed relative to the control sample that contained no chito-oligosaccharide. Data for all the variables were checked for a normal distribution. Oil Red O and free glycerol data were analysed using two-way ANOVA and the statistical model included the effect of concentration, MW and the interaction between concentration and MW. Within each concentration or MW, the means were compared by Tukey's test. The adipogenic marker gene expression, ELISA and promoter assay data were analysed using one-way ANOVA and the means were compared by Tukey's test. Values are expressed as means with their standard errors or standard errors of the difference of the mean, as appropriate.
Results
Cell viability and cytotoxicity
The effects of the four chito-oligosaccharides on the viability and cytotoxicity of confluent 3T3-L1 pre-adipocyte in serum-free medium are presented in the supplementary material (available online at http://www.journals.cambridge.org/bjn). For the cell viability test, the interaction effect of concentration £ MW was non-significant for both 24 and 48 h. After 24 h of incubation, concentration had a significant (P,0·001) effect on cell viability, while cell viability dropped when treated with 4800 mg/ml of all chito-oligosaccharides. The MW had no effect at 24 h. After 48 h of incubation, the concentration and MW had significant effects (P,0·001) on cell viability. Cell viability was most affected with 4800 mg/ml of oligosaccharide and least affected by the MW 5-10 000 Da after 48 h. For cell cytotoxicity, after 24 h of incubation with chito-oligosaccharide, neither concentration nor MW had any effect. However, after 48 h of incubation, the concentration and MW had significant effects (P,0·001). Cell cytotoxicity was most affected with 4800 mg/ml of chito-oligosaccharide and least affected by the MW 5-10 000 Da after 48 h.
MW-dependent inhibitory effect (P, 0·001 and ,0·05) on lipid synthesis. Compared with the control sample (0 mg/ml chito-oligosaccharide), the mean percentage of lipid synthesis values at 600, 1200, 2400 and 4800 mg/ml of chito-oligosaccharides were 71·1, 66·1, 49·5 and 18·8 (SED 3·24), respectively. On the other hand, the mean percentage of lipid synthesis values for , 1000, 1 -3000, 3 -5000 and 5 -10 000 Da chito-oligosaccharides were 53·3, 53·7, 52·7 and 45·0 (SED 3·22), respectively. Among the four chitooligosaccharides evaluated, 5 -10 000 Da had the highest inhibitory effect on lipid synthesis (Fig. 1) . The interaction effect of concentration £ MW on the relative Oil Red O stain was not significant. The concentration effect of one chito-oligosaccharide (5 -10 000 Da) at the single-cell level (40 £ resolution) and that of four chito-oligosaccharides, as observed in the microscopic field (10 £ resolution), are presented in Fig. 2(a) and (b), respectively. It was evident that the control had a large number of intracellular lipid droplets, while those treated with 600-4800 mg/ml of various MW chito-oligosaccharides had a visible reduction in the number and size of the lipid droplets.
Free glycerol release
The effect of chito-oligosaccharide on free glycerol release during adipogenesis is presented in Fig. 3 . Chito-oligosaccharides had a concentration-dependent inhibitory effect (P, 0·001) in free glycerol release, which was not affected by the MW. Compared with the control sample, the relative free glycerol release at 600, 1200, 2400 and 4800 mg/ml of chito-oligosaccharide was 76·0, 66·8, 52·6 and 41·8 % (SED 3·00), respectively. The interaction effect of concentration £ MW on free glycerol release was not significant.
Quantitative expression of adipogenic marker genes
The effect of chito-oligosaccharide (MW 5 -10 000 Da) on the quantitative expression of the four adipogenic marker genes during adipogenesis is presented in Fig. 4 . For all the four marker genes, the control (0 mg/ml chito-oligosaccharide) had the highest level of the abundance of gene transcripts, while treatment with chito-oligosaccharide (600, 1200, 2400 and 4800 mg/ml) resulted in a significant reduction in the transcript abundance level of all the four marker genes in a concentration-dependent manner.
Expression profiling of lipid metabolic genes
Based on the lipid synthesis inhibition profile of the four chitooligosaccharides, the MW 5-10 000 Da was evaluated across the concentrations 600, 2400 and 4800 mg/ml for the regulation of gene expression. The quantitative expression of a total of forty-four genes involved in mouse lipid metabolism is presented in Fig. 5 . These forty-four genes evaluated had either established or a potential role in lipid metabolism, and hence chosen for identifying the genes with modified expression during the chito-oligosaccharide-mediated inhibition of adipogenesis. Across the concentrations tested, the expression level of IL-6 and PTGS2 (also known as cyclo-oxygenase-2) genes had a concentration-dependent increase with chito-oligosaccharide. Compared with the control, at concentrations 600, 2400 and 4800 mg/ml, the expression level of IL-6 gene was up by 4·2, 7·3 and 21·2-fold, respectively (Table 1 ). This expression pattern of the IL-6 gene across the concentration of chito-oligosaccharides indicated an exponential increase (fold change ¼ 3·149 e 0·0004 (chito-oligosaccharide (mg/ml)) , r 2 0·99). The expression level of PTGS2 was also up by 4·2-and 16·9-fold at the chito-oligosaccharide concentrations of 2400 and 4800 mg/ml, respectively (Table 1) . Down-regulation in the expression of a total of twelve genes, mostly involved in lipid biosynthesis (Fig. 5 ), was only evident at the chitooligosaccharide concentration of 4800 mg/ml.
IL-6 promoter transcriptional activity
The stimulatory effect of chito-oligosaccharide on IL-6 gene promoter activity in transiently transfected mouse 3T3-L1 cells (at a post-confluent state) is presented in Fig. 6 . IL-6 promoter transcriptional activity increased (P, 0·001) due to the chito-oligosaccharide treatment in both serum-containing and serum-free cellular environments. Higher levels of IL-6 promoter activity were evident in the serum-containing differentiation medium than in the serum-free medium.
IL-6 ELISA
The abundance of IL-6 at day 8 post-induction of differentiation in the presence of chito-oligosaccharide (5-10 000 Da) is presented in Fig. 7 . The presence of chito-oligosaccharide resulted in the secretion of IL-6 in the cell culture medium in a concentration-dependent manner. While the cells treated with 0 mg/ml of chito-oligosaccharide had only 1·69 (SEM 0·39) pg/ml of IL-6 in the medium, those treated with 600, 1200, 2400 and 4800 mg/ml of chito-oligosaccharide had 26·39 (SEM 2·41), 25·78 (SEM 2·54), 33·13 (SEM 1·38) and 63·28 (SEM 51·6) pg/ml of IL-6 (P,0·001). Secretion of IL-6 over time by the differentiating 3T3-L1 cells in the presence of chito-oligosaccharide (2400 mg/ml) is presented in Fig. 8 . At 0 -48 h post-induction of adipogenesis, chito-oligosaccharide caused a sixteen-fold increase in IL-6 secretion compared with the control. During the 48 -96 and 96 -144 h periods, although IL-6 secretion was relatively small compared with 0 -48 h post-induction of differentiation, the level of IL-6 secretion was considerably high relative to the control samples.
Discussion
Adipogenesis is a vital physiological process, with excessive adipogenesis contributing to the development of obesity. In the present study, all four chito-oligosaccharides examined had concentration-dependent anti-adipogenic activities, with the 5 -10 000 Da chito-oligosaccharide having the most pronounced inhibitory effect on lipid accumulation. To understand the cell-signalling events of the chito-oligosaccharidemediated inhibition of adipogenesis, the expression of a panel of genes in the lipid metabolic pathway was evaluated. These data suggest that during the chito-oligosaccharidemediated inhibition of adipogenesis, up-regulation of the IL-6 gene, and at higher chito-oligosaccharide concentrations, the PTGS2 gene, occurred in a concentration-dependent manner. Stimulatory activity of chito-oligosaccharide on the regulation of the IL-6 gene was also evident at transcription and translation levels. The results of the present study suggest that elevated expression levels of the pro-inflammatory cytokine IL-6, as well as PTGS2, are among the signalling molecules likely to have a fundamental role in the chitooligosaccharide-mediated inhibition of adipogenesis.
The anti-adipogenic potential of chito-oligosaccharide was found to be influenced by the MW, where the 5 -10 000 Da chito-oligosaccharide had the most pronounced inhibitory effect on lipid accumulation. It also had a better cell viability and cytotoxicity profile in comparison with the other MW chito-oligosaccharide. With regard to the anti-adipogenic potential of different MW chito-oligosaccharides, two previous studies have reported varying information. Similar to the present results, Qin et al. reported 5 -10 000 Da to be more effective in weight reduction in mice compared with low (,1000 Da) and medium (1 -3 000 Da) MW chitooligosaccharides. In contrast, 1 -3000 Da was found to be the most effective in inhibiting TAG release during adipogenesis in 3T3-L1 cells when 1 -3000, 3 -5000, 5 -10 000 Da and their mixture were compared (3) . All four chito-oligosaccharides had concentration-dependent anti-adipogenic activities in the mouse 3T3-L1 pre-adipocytes, as reflected by the lipid accumulation (Oil Red O) and free glycerol release data. The anti-adipogenic potential of chito-oligosaccharide (5 -10 000 Da) was further verified through quantifying the expression levels of four adipogenic marker genes (GAPDH, CEBPa, PPARg and ADIPOQ), where the expression levels of these genes were down-regulated by the chito-oligosaccharide treatment. Profiling of mouse 3T3-L1 adipocytes treated with chito-oligosaccharide previously revealed that the inhibitory effect of chito-oligosaccharide on lipid synthesis is mediated by the modulation of adipokines and adipose tissue-specific genes such as CEBPa and PPARg (30) .
To identify the potential candidate genes involved in the chito-oligosaccharide-mediated inhibition of adipogenesis in the mouse 3T3-L1 adipocytes, and to ascertain the key signalling pathways involved, we have evaluated the quantitative expression of a panel of lipid metabolic pathway genes. This panel included representation of genes for various pathways, including lipid biosynthesis and breakdown, cytokine, chemokines, adipokines and their receptors. The genes included in this array had either an established or a potential role in lipid metabolism -a vital metabolic process reportedly affected by chito-oligosaccharides (3) . This screening procedure enabled the identification of a total of fourteen differentially expressed genes. This included two cytokine genes (IL-6 and PTGS2) that were up-regulated and twelve genes, mostly involved in lipid breakdown, that were downregulated. While IL-6 is commonly known for its dual pro-and antiinflammatory functions, it clearly acts as an inhibitor of lipid accumulation and an inducer of fat lipolysis and oxidation in vivo (31 -33) and in vitro (34) . Transgenic mice deficient in the IL-6 gene were found to develop obesity and reverted back to normal once treated with IL-6 (31) . The anti-obesity action of IL-6 was reportedly mediated through an increase in the energy expenditure and breakdown of lipids (31) . Therefore, it may be likely that the high level of IL-6 gene expression in differentiating 3T3-L1 cells treated with chitooligosaccharide is actually responsible for the inhibition of lipid synthesis. Chito-oligosaccharide-mediated inhibition of lipid synthesis both in vitro and in vivo has been reported previously (3, 35) , and the novel finding of the present study is that this inhibition is mostly probably mediated through the IL-6 signalling pathway.
The exact molecular mode of action of IL-6 during the differentiation of pre-adipocytes is not well understood because of the fact that the previous studies on IL-6 used mature adipocytes. IL-6 can directly down-regulate the expression of a number of adipogenic markers, including PPARg, CEBPa and ADIPOQ in adipocytes, which results in decreased adipocyte differentiation and an attenuation of lipid accumulation (36, 37) . This IL-6-mediated suppression of key adipogenic marker genes was reportedly mediated through the mitogen-activated protein kinase extracellular signal-related kinases signalling pathway, which can lead to a reduction in TAG synthesis in adipocytes (37) . Therefore, in the present study, it is possible that the inhibitory role of chito-oligosaccharide on the expression of key adipogenic markers was, at least, partly due to a high level of IL-6 secretion by the 3T3-L1 cells in response to the chito-oligosaccharide treatment during the differentiation process.
In the present study, treatment of differentiating 3T3-L1 cells with chito-oligosaccharide (MW 5-10 000 Da) resulted in an increase in the IL-6 gene expression and IL-6 secretion in the medium across the concentrations tested (600 -4800 mg/ ml). Although a concentration of 4800 mg/ml may be considered too high to attain, under physiological conditions, a concentration-dependent increase in the IL-6 gene and protein was evident even at low chito-oligosaccharide concentrations (600 and 2400 mg/ml). Since the 5 -10 000 Da-treated cells had high cell viability and low cytotoxicity profiles, it is unlikely that the gene expression, ELISA and promoter activity results were a manifestation of cell cytotoxicity caused by chito-oligosaccharide.
Another interesting gene, whose expression level was upregulated by chito-oligosaccharide, was the PTGS2 gene. An up-regulation of the PTGS2 gene was only evident at 2400 and 4800 mg/ml of chito-oligosaccharide, and hence this gene is not considered to be as sensitive as IL-6. In adipose cells, PG endoperoxidase synthase is involved in the conversion of arachidonic acid, which is derived from the membrane phospholipids, to PG (38) . In the 3T3-L1 cells, PGE 2 was found to be abundantly produced at the rapidly growing sub-confluent state and its level gradually dropped when the cell reached the confluent state followed by a substantial reduction during the differentiation phase (39) . The authors have suggested that cessation of cell growth at the confluent state and differentiation phases were associated with the inhibition of PGE 2 production. PGE 2 has also been reported to be a suppressor of the differentiation of 3T3-L1 pre-adipocyte (40) .
In diet-induced obesity of mice, PGE 2 was less abundant in the tissue obtained from obese mice compared with lean mice (41) . In obese human subjects, PGE 2 signalling in white adipose tissue was impaired (42) . In line with the previous reports, the findings of the present study suggest that chitooligosaccharide-mediated inhibition of adipogenesis involved increased PTGS2 gene expression, which is linked to a proinflammatory response.
While the present study does not explore the interactions between IL-6 and PTGS2, it can be hypothesised that the elevated concentrations of IL-6 may influence the expression of the PTGS2 gene. While IL-6 expression was dependent on the concentration of chito-oligosaccharide and expressed at the lowest levels, the PTGS2 expression was only elevated at the higher chito-oligosaccharide concentrations. The promoter region of the PTGS2 gene has two binding sites for CCAAT/enhancer-binding protein-b (CEBPb, also known as NF-IL-6) (43) . The CEBPb transcription factor complex is an IL-6-dependent DNA-binding protein, hence one could expect its transcriptional activity level to increase with increased intracellular abundance of IL-6. In support of this concept, two CEBPb sites present in the promoter region of the PTGS2 gene were important for the higher expression of the PTGS2 gene in activated murine mast cell 34 (43) .
Among the genes whose expression was down-regulated due to the chito-oligosaccharide treatment included many genes involved in the lipid biosynthesis process. The downregulation of the PPARg gene has also been reported to be mediated through the action of PGE 2 , since the latter had an inhibitory role on the expression of PPARg (44) . PPARg is a potent transcription factor, which is a major activator of the differentiation process that ultimately leads to lipid accumulation in adipocytes (45) . Our data support a previous report on the inhibition of PPARg expression at protein and mRNA levels by chito-oligosaccharides (3) . A reduction in the expression of FABP4 and FABP5 genes indicated that chitooligosaccharide-mediated inhibition of adipogenesis may have occurred during the process of fatty acid uptake, transport and metabolism (46) . In adipocytes, the SCD is an important enzyme required for lipid metabolism (47) . It regulates the synthesis of SFA, and a dramatic reduction in the SCD gene expression due to the chito-oligosaccharide treatment indicated a reduction in the synthesis of SFA (47) .
Surprisingly, the genes whose expression was downregulated were conspicuous only when a high concentration of chito-oligosaccharides (4800 mg/ml) was used. Although the cell viability and cytotoxicity data indicate that chito-oligosaccharide at 4800 mg/ml after 48 h of incubation may affect cell health adversely, for the adipogenesis study, it is unlikely that the down-regulation of the genes was a manifestation of the cytotoxicity effect of chito-oligosaccharide. This is primarily because the chito-oligosaccharides in the serum-containing medium used during adipogenesis would likely to have only minimal effect on the cell health compared with the serumfree medium used for the cell viability and cytotoxicity tests (48, 49) . Second, during the adipogenesis process, fresh medium was introduced in every alternate day, which is likely to further minimise the cytotoxic effect due to nutrient depletion in the medium. Third, most of the marker genes of the PCR array had established their roles in the lipid metabolism process and their alteration in expression level was as expected. The exact physiological concentration of chitooligosaccharide, which can be attainable in human subjects without adverse health effect, is presently unknown, although it is suggested that toxic side effects have not yet been reported in human subjects after oral administration of a dose as high as 3 g/d (50) . Similarly, no side effects have been reported in mice after oral administration of a dose of 200-600 mg/kg per d (50, 51) .
In conclusion, we have identified that IL-6, and PTGS2 to a lesser extent, are among the vital signalling molecules in the chito-oligosaccharide-mediated inhibition of adipogenesis in the 3T3-L1 cells. The IL-6 produced by chito-oligosaccharide can cause a breakdown of lipid molecules as well as the prevention of lipid accumulation during adipogenesis, while the high level of PTGS2 gene expression may contribute to the PG-mediated inhibition of the differentiation of pre-adipocytes to adipocytes. Since chito-oligosaccharide has the potential to regulate the expression of IL-6 and PTGS2 genes that may inhibit adipogenesis, further in vivo and in vitro studies would be useful to explore its potential use as a functional food to reduce adipogenesis in human subjects. approved the final version submitted for publication. None of the authors had a financial or personal conflict of interest in relation to the present study. 
